Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 14 (2) , 99-107
- https://doi.org/10.1016/0165-0327(88)90051-1
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- The clinical use of the dexamethasone suppression test in DSM-III affective disorders: Correlation with the severe depressive subtypes of melancholia and psychosisJournal of Psychiatric Research, 1987
- The Dexamethasone Suppression TestThe British Journal of Psychiatry, 1986
- Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed PatientsScience, 1984
- CSF monoamine metabolites in melancholiaActa Psychiatrica Scandinavica, 1984
- Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal bloodBrain Research, 1983
- Lack of Effect of Serotonin and Norepinephrine on CRF Release from HypothalamiIn VitroHormone and Metabolic Research, 1983
- Role of serotonin in the control of secretion of corticotrophin releasing factorJournal of Endocrinology, 1982
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- NEUROTRANSMITTER REGULATION OF CORTICOTROPIN‐RELEASING FACTOR IN VITROAnnals of the New York Academy of Sciences, 1977
- Role of biogenic amines in certain pathological conditionsBrain Research, 1975